Delaware
|
000-50590
|
11-3516358
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR
240.13e-4(c))
|
Item
1.01
|
Entry
into a Material Definitive Agreement.
|
Item
5.02.
|
Departure
of Directors or Principal Executive Officers; Election of Directors;
Appointment of Principal
Officers.
|
Item
9.01.
|
Financial
Statements and Exhibits.
|
(c)
|
Exhibits.
|
10.1
|
Extension
of Stock Option Agreements dated May 2, 2006 by and between Rexahn
Pharmaceuticals, Inc. and John
Holaday.
|
REXAHN
PHARMACEUTICALS, INC.
|
|||
(Registrant)
|
|||
By
|
/s/
Chang H. Ahn
|
||
Chang
H. Ahn
|
|||
Chairman
and Chief Executive Officer
|
Exhibit
Number
|
Description
|
Extension
of Stock Option Agreements dated May 2, 2006 by and between Rexahn
Pharmaceuticals, Inc. and John
Holaday.
|